Efficacy of oral active ether lipid analogs of cidofovir in a lethal mousepox model
- 1 January 2004
- Vol. 318 (2) , 474-481
- https://doi.org/10.1016/j.virol.2003.11.015
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Esterification of cidofovir with alkoxyalkanols increases oral bioavailability and diminishes drug accumulation in kidneyAntiviral Research, 2003
- Increased Antiviral Activity of 1-O-Hexadecyloxypropyl-[2-14C]cidofovir in MRC-5 Human Lung Fibroblasts Is Explained by Unique Cellular Uptake and MetabolismMolecular Pharmacology, 2003
- Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infectionsAntiviral Research, 2003
- Alkoxyalkyl Esters of Cidofovir and Cyclic Cidofovir Exhibit Multiple-Log Enhancement of Antiviral Activity against Cytomegalovirus and Herpesvirus Replication In VitroAntimicrobial Agents and Chemotherapy, 2002
- Treatment of aerosolized cowpox virus infection in mice with aerosolized cidofovirAntiviral Research, 2001
- Cidofovir Protects Mice against Lethal Aerosol or Intranasal Cowpox Virus ChallengeThe Journal of Infectious Diseases, 2000
- Acyclic Nucleoside Phosphonates: A New Dimension To The Chemotherapy Of Dna Virus And Retrovirus InfectionsJournal of Medical Microbiology, 1998
- Mechanism of uptake of the phosphonate analog (S)-1-(3-hydroxy-2-phosphonylmethoxy-propyl)cytosine (HPMPC) in vero cellsBiochemical Pharmacology, 1993
- Restricted replication of ectromelia virus in cell culture correlates with mutations in virus-encoded host range geneVirology, 1992
- Poxvirus pathogenesis.Microbiological Reviews, 1991